Camp4 Therapeutics Corp (CAMP): Total Liabilities
$70.10M
As of 2025-12-31
$94.12M
As of 2026-06-30
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $70.10M | +362.3% | 2026-03-05, Balance as of period end |
| 2024-12-31 | $15.16M | -8.3% | 2026-03-05, Balance as of period end |
| 2023-12-31 | $16.53M | n/a | 2025-03-27, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $70.10M | +362.3% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $2.27M | -34.4% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $4.66M | +20.0% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $10.78M | -5.9% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $968.0K | +8.2% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $8.26M | +15.7% |
| Upstream Bio, Inc. (UPB) | 2025-12-31 | $14.00M | +18.0% |
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | $56.36M | +0.9% |
| Cartesian Therapeutics, Inc. (RNAC) | 2025-12-31 | $422.65M | -4.3% |
Compare CAMP, MRKR, CRVO, TXMD side by side · Screen every company in Pharmaceutical Preparations ↗